| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 03/08/2007 | US20070054898 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054892 Isoquinoline potassium channel inhibitors |
| 03/08/2007 | US20070054891 e.g. 3-(2,4,4'-trichlorobenzhydryloxy)-N-(tert-butyl)azetidine-1-carboxamide; cannabinoid receptor antagonist; antidiabetic agent, antidepressant; eating disorders, obesity, nicotine addiction |
| 03/08/2007 | CA2822094A1 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 03/08/2007 | CA2621182A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| 03/08/2007 | CA2620818A1 Amide derivatives as rock inhibitors |
| 03/08/2007 | CA2620688A1 Heterocyclic compound |
| 03/08/2007 | CA2620425A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 03/08/2007 | CA2620085A1 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 03/08/2007 | CA2619912A1 Novel cycloalkane carboxamides as factor xa inhibitors |
| 03/08/2007 | CA2619566A1 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2619450A1 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2619448A1 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2619287A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/07/2007 | EP1760103A1 Arylamine polymer and organic thin film transistor |
| 03/07/2007 | EP1760080A1 Design and synthesis of thiophene derived NLO materials for electro-optic applications |
| 03/07/2007 | EP1760076A1 FAP Inhibitors |
| 03/07/2007 | EP1758921A2 Compounds for proteasome enzyme inhibition |
| 03/07/2007 | EP1758895A1 Gonadotropin releasing hormone receptor antagonists |
| 03/07/2007 | EP1758894A1 Heterocyclic carboxamides with microbiocidal activity |
| 03/07/2007 | EP1758883A1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors |
| 03/07/2007 | EP1758869A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 03/07/2007 | EP1758864A1 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 03/07/2007 | EP1758857A1 Indole derivatives as antiviral agents |
| 03/07/2007 | EP1758583A2 Arylpiperazine derivatives useful as adrenergic receptor antagonists |
| 03/07/2007 | EP1758582A1 Amido compounds and their use as pharmaceuticals |
| 03/07/2007 | EP1187811B1 Inhibitors of metalloproteinases |
| 03/07/2007 | EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics |
| 03/07/2007 | CN1926148A Beta-aminoacid-derivatives as factor Xa inhibitors |
| 03/07/2007 | CN1926134A 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 03/07/2007 | CN1926132A Pyrazole compounds useful as protein kinase inhibitors |
| 03/07/2007 | CN1926129A Novel insecticides |
| 03/07/2007 | CN1926117A 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 03/07/2007 | CN1926108A Non-nucleotide reverse transcriptase inhibitors |
| 03/07/2007 | CN1926104A Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators |
| 03/07/2007 | CN1926103A Sulphonylpyrroles as HDAC inhibitors |
| 03/07/2007 | CN1923812A New compounds |
| 03/07/2007 | CN1303071C Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof |
| 03/07/2007 | CN1303066C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 03/07/2007 | CN1303063C Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient |
| 03/06/2007 | US7186849 C7 ester substituted taxanes |
| 03/06/2007 | US7186833 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 03/06/2007 | US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 03/06/2007 | US7186743 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics |
| 03/06/2007 | US7186735 Vasodilation; cardiovascular disorders; anticoagulants |
| 03/06/2007 | US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders |
| 03/06/2007 | US7186733 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/06/2007 | US7186731 2-cyanopyrrolidinecarboxamide compound |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | US7186722 active against sensitive and resistant species and against all development stages |
| 03/06/2007 | US7186717 Pyrrolidine derivatives as Factor Xa inhibitors |
| 03/06/2007 | US7186715 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 03/06/2007 | US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders |
| 03/06/2007 | US7186709 Subjecting a vinyl ethers and an unsaturated ketoester to suitable conditions to generate a scaffold having the core dihydropyrancarboxamide or dihydropyrancarboxylic ester or acid; anticarcinogenic agents |
| 03/06/2007 | CA2384525C Thienylhydrazon with digitalis-like properties (positive inotropic effects) |
| 03/01/2007 | WO2007023186A1 Pyrazine derivatives and use as pi3k inhibitors |
| 03/01/2007 | WO2007022964A2 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| 03/01/2007 | WO2007022947A2 5-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors |
| 03/01/2007 | WO2007022946A1 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors |
| 03/01/2007 | WO2007022938A2 Compounds |
| 03/01/2007 | WO2007022845A1 Novel materials for organic electroluminescent devices |
| 03/01/2007 | WO2007022638A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 03/01/2007 | WO2007002181A3 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
| 03/01/2007 | WO2006036994A3 Modulators of crth2, cox-2 and faah |
| 03/01/2007 | WO2005117882A9 Hydroxamic acid derivatives as metalloprotease inhibitors |
| 03/01/2007 | WO2005117876A8 Dual small molecule inhibitors of cancer and angiogenesis |
| 03/01/2007 | US20070049621 6-Alkylamino-2-methyl-2'-(N-methyl substituted sulfonamido)methyl-2H-1-benzopyran derivative as anti-inflammatory inhibitor |
| 03/01/2007 | US20070049605 5H-Dibenzo[c,g]chromene-3,9-diol; estrogen receptor modulators; osteoporosis |
| 03/01/2007 | US20070049601 BENZOFURAN INHIBITORS OF FACTOR VIIa |
| 03/01/2007 | US20070049587 Factor Xa inhibitors |
| 03/01/2007 | US20070049584 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine |
| 03/01/2007 | US20070049570 Quinoline derivatives as phosphodiesterase inhibitors |
| 03/01/2007 | US20070049536 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis |
| 03/01/2007 | US20070049495 1-Methyl, 3-trifluoromethyl,4-(2-(4-(tert-butylpyrazol-1-yl),2-cyano,1-tert-butylcarbonyloxy)ethylene)-pyrazole; agriculture; preventing the attachment of aquatic organisms to boats, construction materials, heat excangers; coolants; water supply systems; engineering plants; reservoirs; marine/underwater |
| 03/01/2007 | US20070045618 Organic semiconductor material, organic semiconductor element and field effect transistor using the same |
| 03/01/2007 | CA2620414A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 03/01/2007 | CA2618479A1 Pyrazine derivatives and use as pi3k inhibitors |
| 02/28/2007 | EP1757600A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 02/28/2007 | EP1757591A1 Cinnamide compound |
| 02/28/2007 | EP1757584A1 Heterocyclic substituted amides, their production and their use |
| 02/28/2007 | EP1757582A1 Arylalkylamines and process for production thereof |
| 02/28/2007 | EP1756193A1 Monomer, oligomer and pi-conjugated polymer compounds, and photovoltaic cells containing same |
| 02/28/2007 | EP1756109A1 Novel indole derivatives as selective androgen receptor modulators (sarms) |
| 02/28/2007 | EP1756096A1 Indolyl derivatives as liver-x-receptor modulators |
| 02/28/2007 | EP1756091A1 Non nucleoside reverse transcriptase inhibitors |
| 02/28/2007 | EP1756084A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/28/2007 | EP1756082A1 5-morpholinylmethylthiophenyl pharmaceutial compounds as p38 map kinase modulators |
| 02/28/2007 | EP1507776B1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 02/28/2007 | EP1501795B1 Cinnamic acid amides |
| 02/28/2007 | EP1458703B1 Isochroman compounds for treatment of cns disorders |
| 02/28/2007 | EP1441734B1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1397350B1 Isoquinolinone derivatives as parp inhibitors |
| 02/28/2007 | EP1370531B1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | EP1102753B1 Pyrazoles as estrogen receptor modulators |
| 02/28/2007 | CN1922174A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 02/28/2007 | CN1922172A Substituted heterocyclic compounds and uses thereof |
| 02/28/2007 | CN1922151A Substituted azole derivatives, compositions, and methods of use |